SECUKINUMAB

secukinumab 150 mg/mL injection, 1 mL pen device

SECUKINUMAB (12307R)

secukinumab 150 mg/mL injection, 1 mL pen device
12307R
Manner of administration:Injection
General Schedule
Authority Required

Restriction

Indication: Non-radiographic axial spondyloarthritis
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 5 DPMQ: $676.80 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Cosentyx